Cory H. - Chief Scientific Officer at Lung Therapeutics

Cory H. has a long and distinguished career in medicine. In 2021, they began working as the Chief Scientific Officer for Lung Therapeutics, Inc.

Mining Patient Records to Help Crack the Code of COVID-19

Penn announces nine 2024 Thouron Scholars

Steering committee of pulmonary and primary care experts aims to

Our Mission - Thompson Heath

Drug-Induced Pulmonary Toxicity: Practice Essentials, Background

Cory Robinson, PhD, MHA, PMP, FACHE, College of Medicine

Vertex's big move beyond cystic fibrosis hits a wall with lung

American Cancer Society Professors

Greffex Transforms Vaccine and Gene Therapy Work - Colorado

Our People Break Through Cancer

UC Davis PD Hires First DACA Officer